Huang, H., Yan, Z., Chen, Y. & Liu, F. A social contagious model of the obesity epidemic. Sci. Rep. 6, 37961–37970 (2016).
Google Scholar
Tabrizi, J. S., Sadeghi-Bazargani, H., Farahbakhsh, M., Nikniaz, L. & Nikniaz, Z. Prevalence and associated factors of overweight or obesity and abdominal obesity in Iranian population: a population-based study of northwestern Iran. Iran. J. Public Health. 47, 1583–1592 (2018).
Google Scholar
Blüher, M. Obesity: global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 15, 288–298 (2019).
Google Scholar
Bray, G. A., Kim, K. K. & Wilding, J. P. H. Obesity: A chronic relapsing progressive disease process: A position statement of the World Obesity Federation. Obes. Rev. 18, 715–723 (2017).
Google Scholar
Gol, S., Pena, R. N., Rothschild, M. F., Tor, M. & Estany, J. A polymorphism in the fatty acid desaturase-2 gene is associated with the arachidonic acid metabolism in pigs. Sci. Rep. 8, 1–9 (2018).
Google Scholar
He, Z. et al. FADS1-FADS2 genetic polymorphisms are associated with fatty acid metabolism through changes in DNA methylation and gene expression. Clin. Epigenetics. 10, 1–13 (2018).
Google Scholar
Bláhová, Z., Harvey, T. N., Pšenička, M. & Mráz, J. Assessment of fatty acid desaturase (Fads2) structure-function properties in fish in the context of environmental adaptations and as a target for genetic engineering. Biomolecules 10, 1–13 (2020).
Google Scholar
Brown, K. M. et al. Delta-6-desaturase (FADS2) inhibition and omega-3 fatty acids in skeletal muscle protein turnover. Biochem. Biophys. Rep. 18, 100622–100629 (2019).
Google Scholar
Mazoochian, L., Mir Mohammad Sadeghi, H. & Pourfarzam, M. The effect of FADS2 gene rs174583 polymorphism on desaturase activities, fatty acid profile, insulin resistance, biochemical indices, and incidence of type 2 diabetes. JRMS. 23, 47 (2018).
Google Scholar
Egaña-Gorroño, L. et al. Receptor for advanced glycation end products (RAGE) and mechanisms and therapeutic opportunities in diabetes and cardiovascular disease: Insights from human subjects and animal models. Front. Cardiovasc. Med. 7, 37–52 (2020).
Google Scholar
Sergi, D., Boulestin, H., Campbell, F. M. & Williams, L. M. The role of dietary advanced glycation end products in metabolic dysfunction. Mol. Nutr. Food. Res. 65, e1900934-1900945 (2021).
Google Scholar
Bettiga, A. et al. The modern western diet rich in advanced glycation end-products (AGEs): An overview of its impact on obesity and early progression of renal pathology. Nutrients 11, 1–19 (2019).
Google Scholar
Tessier, F. J. & Birlouez-Aragon, I. Health effects of dietary Maillard reaction products: The results of ICARE and other studies. Amino Acids 42, 1119–1131 (2012).
Google Scholar
Ribeiro, P. V. M., Tavares, J. F., Costa, M. A. C. & Mattar, J. B. G. Effect of reducing dietary advanced glycation end products on obesity-associated complications: A systematic review. Nutr. Rev. 77, 725–734 (2019).
Google Scholar
Tavares, J. F., Ribeiro, P. V. M., Coelho, O. G. L., Silva, L. E. D. & Alfenas, R. C. G. Can advanced glycation end-products and their receptors be affected by weight loss? A systematic review. Obes. Rev. 21, 1–13 (2020).
Uribarri, J. et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J. Am. Diet. Assoc. 110, 911–16.e12 (2010).
Google Scholar
Tessier, F. J. et al. Quantitative assessment of organ distribution of dietary protein-bound 13C-labeled Nɛ-carboxymethyllysine after a chronic oral exposure in mice. Mol. Nutr. Food Res. 60, 2446–2456 (2016).
Google Scholar
Gaens, K. H. J. et al. Nε-(carboxymethyl) lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance. ATVB. 34, 1199–1208 (2014).
Google Scholar
Clarke, R. E., Dordevic, A. L., Tan, S. M., Ryan, L. & Coughlan, M. T. Dietary advanced glycation end products and risk factors for chronic disease: A systematic review of randomised controlled trials. Nutrients 8, 125–151 (2016).
Google Scholar
Sohouli, M. H., Sharifi-Zahabi, E., Lari, A. & Fatahi, S. F. S. The impact of low advanced glycation end products diet on obesity and related hormones: a systematic review and meta-analysis. Sci. Rep. 10, 22194–22205 (2020).
Google Scholar
Stütz, A. M., Morrison, C. D. & Argyropoulos, G. The Agouti-related protein and its role in energy homeostasis. Peptides 26, 1771–1781 (2005).
Google Scholar
Abe, Y. et al. Melanin synthesis induction by advanced glycation end-products (AGEs) without α-melanocyte stimulating hormone (α-MSH) or UV exposure. Glycative Stress Res. 3, 229–235 (2016).
Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813–820 (2001).
Google Scholar
Booth, M. Assessment of physical activity: an international perspective. Res. Q. Exerc. Sport. 71, 114–120 (2000).
Google Scholar
Kouchi, M. Anthropometric methods for apparel design: Body measurement devices and techniques. In Anthropometry, Apparel Sizing and Design 67–94 (Elsevier, 2014).
Google Scholar
Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972).
Google Scholar
Gutch, M., Kumar, S., Razi, S. M., Gupta, K. K. & Gupta, A. Assessment of insulin sensitivity/resistance. Indian. J. Endocrinol. Metab. 19, 160–164 (2015).
Google Scholar
Katz, A. et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 85, 2402–2410 (2000).
Google Scholar
Hosseini-Esfahani, F., Asghari, G., Mirmiran, P. & Azizi, F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J. Epidemiol. 20, 150–158 (2010).
Google Scholar
Mirmiran, P., Hosseini-Esfahani, F., Mehrabi, Y., Hedayati, M. & Azizi, F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 13, 654–662 (2010).
Google Scholar
Ghaffarpour, M., Houshiar-Rad, A. & Kianfar, H. The manual for household measures, cooking yields factors and edible portion of foods. Tehran Nashre Olume Keshavarzy. 7, 42–58 (1999).
Goldberg, T. et al. Advanced glycoxidation end products in commonly consumed foods. J. Am. Diet. Assoc. 104, 1287–1291 (2004).
Google Scholar
Malerba, G. et al. SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 43, 289–299 (2008).
Google Scholar
Hu, L. T. & Bentler, P. M. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct. Equ. Modeling. 6, 1–55 (1999).
Google Scholar
Ghorbaninejad, P. et al. A negative association of dietary advanced glycation end products with obesity and body composition in Iranian adults. Br. J. Nutr. 125, 471–480 (2021).
Google Scholar
Uribarri, J. et al. Circulating glycotoxins and dietary advanced glycation endproducts: Two links to inflammatory response, oxidative stress, and aging. J. Gerontol. A. 62, 427–433 (2007).
Google Scholar
Mirmiran, P., Hadavi, H., Mottaghi, A. & Azizi, F. Advanced glycation end products and risk of general and abdominal obesity in Iranian adults: Tehran lipid and glucose study. MJIRI 33, 21–28 (2019).
Google Scholar
Leuner, B. et al. RAGE influences obesity in mice. Z. Gerontol. Geriatr. 45, 102–108 (2012).
Google Scholar
Angoorani, P., Ejtahed, H. S., Mirmiran, P., Mirzaei, S. & Azizi, F. Dietary consumption of advanced glycation end products and risk of metabolic syndrome. Int. J. Food. Sci. Nutr. 67, 170–176 (2016).
Google Scholar
Vistoli, G. et al. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): An overview of their mechanisms of formation. Free Radic. Res. 47, 3–27 (2013).
Google Scholar
Münch, G. et al. Amino acid specificity of glycation and protein–AGE crosslinking reactivities determined with a dipeptide SPOT library. Nat. Biotechnol. 17, 1006–1010 (1999).
Google Scholar
Poulsen, M. W. et al. Effect of dietary advanced glycation end products on postprandial appetite, inflammation, and endothelial activation in healthy overweight individuals. Eur. J. Nutr. 53, 661–672 (2014).
Google Scholar
Tahara, N. et al. Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects. Cardiovasc. Ther. 30, 42–48 (2012).
Google Scholar
Uribarri, J. et al. Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: A link between healthy and unhealthy obesity?. J. Clin. Endocrinol. Metab. 100, 1957–1966 (2015).
Google Scholar
Mendoza-Herrera, K. et al. Association of dietary advanced glycation end products with metabolic syndrome in young Mexican adults. Medicines. 5, 128–138 (2018).
Google Scholar
Cai, W. et al. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. PNAS 109, 15888–15893 (2012).
Google Scholar
Wang, S. et al. Linoleic acid and stearic acid elicit opposite effects on AgRP expression and secretion via TLR4-dependent signaling pathways in immortalized hypothalamic N38 cells. Biochem. Biophys. Res. Commun. 471, 566–571 (2016).
Google Scholar
